Publication Cover
Journal of Environmental Science and Health, Part B
Pesticides, Food Contaminants, and Agricultural Wastes
Volume 23, 1988 - Issue 2
20
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Toxicity of pirimiphos‐methyl: I. The acute and subacute oral toxicity in albino rats

&
Pages 127-144 | Received 13 Nov 1986, Published online: 21 Nov 2008
 

Abstract

In an acute study, albino rats of both sexes were orally administered graded doses of Pirimiphosmethyl, and the statistically computed median lethal dose (LD‐50) were 1861 and 1667 mg/kg body weight for male and female rats respectively. No treatment related changes were discernible with regard to food intake, growth, gross or histopathology of the organs. In a time‐course study, the correlation between symptoms and degree of esterase inhibition was examined in rats administered the minimum lethal dose (MLD : 1000 mg/kg b.w.) of the insecticide. Time ‐ course inhibition pattern of both cholinesterase (ChE) and non‐specific carboxylesterase (NSE) activities in brain and plasma revealed maximum inhibition at 24 h post‐treatment which correlated well with the intensity of symptoms.

In a subacute study, groups of male rats were fed dietary Pirimiphos‐methyl at 0, 10, 250, 500 and 1000 ppm for 28 days. Food consumption and growth rate were not affected throughout the experimental period. At necropsy after 28 days, no gross pathological changes were seen in any of the organs except a slight increase in liver weight at 1000 ppm. Though no statistical differences were observed in the levels of hepatic transaminases, a significant increase in serum transaminase wasevident. Significant increase in the activities of hepatic ALP, β‐GLR and serum ALP were evident at 500 and 1000 ppm. Further, significant inhibition of plasma PChE was evident at 250, 500 and 1000 ppm while the degree of inhibition of brain AChE was significant only at the higher dosages. No histopathological alterations were observed in any of the organs.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.